Viveve Medical (NASDAQ:VIVE) Trading Down 7.7%

Viveve Medical Inc (NASDAQ:VIVE) shares fell 7.7% during mid-day trading on Monday . The company traded as low as $0.11 and last traded at $0.12, 7,276,426 shares were traded during trading. An increase of 390% from the average session volume of 1,485,001 shares. The stock had previously closed at $0.13.

A number of research firms recently issued reports on VIVE. Maxim Group reissued a “hold” rating on shares of Viveve Medical in a research report on Friday, August 9th. Stifel Nicolaus downgraded shares of Viveve Medical from a “buy” rating to a “hold” rating and dropped their target price for the stock from $3.00 to $1.00 in a research report on Monday, July 22nd. Mizuho downgraded shares of Viveve Medical from a “buy” rating to an “underperform” rating and dropped their target price for the stock from $4.00 to $0.20 in a research report on Tuesday, July 23rd. Raymond James downgraded shares of Viveve Medical from an “outperform” rating to a “market perform” rating in a research report on Tuesday, July 23rd. Finally, LADENBURG THALM/SH SH downgraded shares of Viveve Medical from a “buy” rating to a “neutral” rating in a research report on Wednesday, July 24th. One investment analyst has rated the stock with a sell rating and six have assigned a hold rating to the company’s stock. The stock has an average rating of “Hold” and a consensus target price of $2.24.

The stock has a market cap of $5.99 million, a PE ratio of -0.08 and a beta of -0.21. The stock has a fifty day simple moving average of $0.26 and a two-hundred day simple moving average of $0.61. The company has a debt-to-equity ratio of 6.21, a quick ratio of 3.43 and a current ratio of 2.98.

Hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Bank of New York Mellon Corp boosted its holdings in Viveve Medical by 266.6% in the 4th quarter. Bank of New York Mellon Corp now owns 45,223 shares of the company’s stock worth $47,000 after acquiring an additional 32,888 shares during the period. Geode Capital Management LLC boosted its holdings in Viveve Medical by 13.6% in the 4th quarter. Geode Capital Management LLC now owns 216,566 shares of the company’s stock worth $227,000 after acquiring an additional 25,975 shares during the period. Meitav Dash Investments Ltd. boosted its holdings in Viveve Medical by 30.1% in the 1st quarter. Meitav Dash Investments Ltd. now owns 988,573 shares of the company’s stock worth $955,000 after acquiring an additional 228,517 shares during the period. Finally, Pennsylvania Trust Co boosted its holdings in Viveve Medical by 212.3% in the 1st quarter. Pennsylvania Trust Co now owns 42,154 shares of the company’s stock worth $7,681,000 after acquiring an additional 28,654 shares during the period. Hedge funds and other institutional investors own 52.75% of the company’s stock.

Viveve Medical Company Profile (NASDAQ:VIVE)

Viveve Medical, Inc designs, develops, manufactures, and markets medical devices for the non-invasive treatment of various post-partum conditions. The company offers Viveve System, a radio frequency generator, a reusable hand piece, and single-use treatment tip, as well as other consumable components.

Recommended Story: Why is a lock-up period needed for an IPO?

Receive News & Ratings for Viveve Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Viveve Medical and related companies with MarketBeat.com's FREE daily email newsletter.